-
561
Synthetic Medical Images for Robust, Privacy-Preserving Training of Artificial Intelligence
Published 2022-06-01Get full text
Article -
562
-
563
Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial
Published 2019-02-01“…Secondary outcomes (at 24 months) include change in binocular best corrected visual acuity; CST; mean deviation of the Humphrey 10–2 visual field; change in percentage of people meeting driving standards; European Quality of Life-5 Dimensions, National Eye Institute Visual Functioning Questionnaire-25 and VisQoL scores; incremental cost per quality-adjusted life year gained; side effects; number of laser treatments and use of additional therapies. …”
Get full text
Article -
564
-
565
-
566
-
567
SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectru...
Published 2023-02-01“…Satralizumab monotherapy (120 mg) will be administered subcutaneously at Weeks 0, 2, 4, and Q4W thereafter for a total of 92 weeks.EndpointsDisease activity related to relapses (proportion relapse-free, annualized relapse rate, time to relapse, and relapse severity), disability progression (Expanded Disability Status Scale), cognition (Symbol Digit Modalities Test), and ophthalmological changes (visual acuity; National Eye Institute Visual Function Questionnaire-25) will all be assessed. …”
Get full text
Article -
568
Combining brain perturbation and neuroimaging in non-human primates
Published 2021-07-01Get full text
Article -
569
Genome-wide screening reveals the genetic basis of mammalian embryonic eye development
Published 2023-02-01Get full text
Article -
570
Cold protection allows local cryotherapy in a clinical-relevant model of traumatic optic neuropathy
Published 2022-03-01Get full text
Article -
571
-
572
Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT
Published 2022-12-01“…Secondary outcomes included the mean change from baseline to 24 months in the following: binocular best-corrected visual acuity; central retinal subfield thickness; the mean deviation of the Humphrey 10–2 visual field in the study eye; the percentage of people meeting driving standards; and the EuroQol-5 Dimensions, five-level version, National Eye Institute Visual Function Questionnaire – 25 and Vision and Quality of Life Index scores. …”
Get full text
Article